1. Home
  2. AMPG vs IMUX Comparison

AMPG vs IMUX Comparison

Compare AMPG & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitech Group Inc.

AMPG

Amplitech Group Inc.

HOLD

Current Price

$1.80

Market Cap

66.2M

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$1.09

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPG
IMUX
Founded
2002
2016
Country
United States
United States
Employees
47
66
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.2M
75.2M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
AMPG
IMUX
Price
$1.80
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$4.80
AVG Volume (30 Days)
372.8K
2.8M
Earning Date
03-26-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$168.18
N/A
Revenue Next Year
$100.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.21
$0.51
52 Week High
$4.89
$1.51

Technical Indicators

Market Signals
Indicator
AMPG
IMUX
Relative Strength Index (RSI) 26.76 49.07
Support Level N/A $1.07
Resistance Level $2.85 $1.17
Average True Range (ATR) 0.17 0.11
MACD -0.03 -0.02
Stochastic Oscillator 5.86 6.82

Price Performance

Historical Comparison
AMPG
IMUX

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: